Liminatus Pharma, Inc. Class A Common Stock (LIMN)
search
Earnings reactions
How LIMN moved on each past earnings report.
Up
Down
Earnings Impact
Liminatus Pharma, Inc. Class A Common Stock (LIMN) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
Historical Earnings Statistics
Liminatus Pharma, Inc. Class A Common Stock (LIMN) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
event
Earnings Count
0
Total earnings in dataset
trending_up
Avg Abs. Movement
±0.00%
Avg % price change on earnings
account_balance
View all 6 →
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
6
Funds holding
$13159
Total value held
Buying
4 added · 1 reduced
Goldman Sachs Group Inc
$4440
NEW BUY
Stonex Group Inc.
$3934
NEW BUY
Ubs Group Ag
$2178
NEW BUY
State Street Corp
$2098
Held
Barclays Plc
$474
NEW BUY
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260818 | open_in_new SEC.gov |
| 10-Q | 20260814 | open_in_new SEC.gov |
| 8-K | 20260804 | open_in_new SEC.gov |
| 8-K | 20260730 | open_in_new SEC.gov |
| 8-K | 20260724 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260722 | open_in_new SEC.gov |
| 4 | 20260714 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260714 | open_in_new SEC.gov |
| DEF 14A | 20260713 | open_in_new SEC.gov |
| 3 | 20260706 | open_in_new SEC.gov |